Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Agios Pharmaceuticals' Change in Inventory fell 5240.77% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 3877.66%. This contributed to the annual value of $8.5 million for FY2024, which is 1931.22% down from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Change in Inventory of $1.2 million as of Q3 2025, which was down 5240.77% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Change in Inventory registered a high of $4.3 million during Q2 2023, and its lowest value of $867000.0 during Q2 2024.
  • Moreover, its 4-year median value for Change in Inventory was $1.8 million (2023), whereas its average is $2.1 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first surged by 17282.54% in 2023, then crashed by 7982.31% in 2024.
  • Quarter analysis of 4 years shows Agios Pharmaceuticals' Change in Inventory stood at $3.3 million in 2022, then plummeted by 45.66% to $1.8 million in 2023, then plummeted by 34.13% to $1.2 million in 2024, then fell by 0.08% to $1.2 million in 2025.
  • Its Change in Inventory was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $2.0 million in Q1 2025.